4.0
Jun 19, 2025
Current employee, more than 1 year
Recommend
CEO approval
Business Outlook
Pros
Be part of the early generation driving the setup of new processes post Sandoz spin off from Novartis, never a dull moment
Cons
Workload could be high mainly due to the company still in build up phase